Atea Pharmaceuticals, Inc. (AVIR)

4.67 +0.05 (+1.08%) USD  |  NASDAQ  |  Feb 26, 16:00
4.67 0.00 (0.00%) After-Hours: 20:00
More

Atea Pharmaceuticals Net Change in Capital Expenditures (Quarterly)

Net Change in Capital Expenditures (Quarterly) Chart

View Net Change in Capital Expenditures (Quarterly) for AVIR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Change in Capital Expenditures (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Net Change in Capital Expenditures (Quarterly) Range, Past 5 Years

View Net Change in Capital Expenditures (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Change in Capital Expenditures (Quarterly) Benchmarks

View Net Change in Capital Expenditures (Quarterly) Benchmarks
Start Trial
Oramed Pharmaceuticals, Inc. Upgrade
Aclaris Therapeutics, Inc. Upgrade
PMV Pharmaceuticals, Inc. Upgrade
Instil Bio, Inc. Upgrade
Coya Therapeutics, Inc. Upgrade